A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection

Long-acting HIV Pre-exposure Prophylaxis (PrEP) Approaches: Recent advances, emerging technologies, and development challenges

This review from Expert Opinion on Drug Delivery discusses the current state of the long acting PrEP field, recent advances, and emerging technologies, including ARV prodrug modifications and new drug delivery systems. Technological challenges, knowledge gaps, preclinical testing considerations, and future directions important in the context of clinical translation and implementation of long acting HIV…

End-user Research in Support of Long-acting Systemic Antiretroviral Delivery Systems: Insights from qualitative research with providers and target users in South Africa

This article from BMC Infectious Diseases describes qualitative research investigating perceptions of and preferences for a long-acting, biodegradable implantable PrEP product designed to address challenges relating to adhering to a daily pill regimen amongst adolescent girls and young women and sex workers in Guateng Province, South Africa.

More than Just Oral PrEP: Exploring interest in rectal douche, dissolvable implant, removable implant and injection HIV prevention approaches among racially diverse men who have sex with men in the Northeast Corridor

This exploratory and cross-sectional study investigated interest in four biomedical prevention tools—rectal douche, dissolvable implant, removable implant and injection—among a racially diverse sample of men who have sex with men from the Northeast Corridor region between Philadelphia and Trenton.

HIV Prevention Research and Development Database

The HIV Prevention Research & Development Database is a comprehensive source of information on biomedical HIV prevention clinical trials that are planned, ongoing or completed. The database allows users to view clinical trials around the world, gaining an understanding of the many developments currently being made in the field of HIV prevention research.

The Years Ahead in Biomedical HIV Prevention Research

The Future of ARV-Based Prevention and More

Measuring Social Harms in Research and Programs on Women-Initiated HIV Prevention Methods

Recent studies of female-initiated HIV prevention products suggest experiences of social harm, including intimate partner violence (IPV), may inhibit some women’s ability to consistently use HIV prevention products. Documenting experiences of social harm is critical for women’s safety and successful use of HIV prevention. This brief summarizes how five HIV prevention trials defined and measured…

What Have We Learned About Adolescent Girls and Young Women and HIV Prevention?

Using survey data collected from ongoing, planned and completed projects studying HIV prevention for adolescent girls and young women, it is possible to identify trends and gaps in the data, and provide a clear snapshot of what we know now.

The Landscape For End User Research: Mapping and Findings

The HIV Prevention Market Manager undertook an effort to map the landscape of ongoing and planned work on bringing HIV prevention to adolescent girls and young women and other populations in sub-Saharan Africa. This document provides a summary and analysis of the end-user projects and studies underway. This information can be used to inform collaborations…

Kenya PrEP Communications Landscape Analysis

McCann Global Health conducted this situation analysis of all available communication on HIV prevention and PrEP for target audiences in Kenya. This analysis was used to identify gaps in market intelligence that should be further explored. The following presentation outlines the findings.